DOCSLIB.ORG

DNA Assembly & Synthetic Biology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Now includes NEBExpress® Cell-free E. coli Protein Synthesis System DNA Assembly & Synthetic Biology TOOLS TO SUPPORT DESIGN AND DNA ASSEMBLY 1 0 01 0 1 SYNTHETIC BIOLOGY DNA Assembly & Synthetic Biology – Tools to support your design and assembly The goal of synthetic biology, in which genes and proteins are viewed as parts or devices, is redesigning and/or assembling them in novel ways to create a new and useful functionality. These projects often rely on the ordered assembly of multiple DNA sequences to create large, artificial DNA structures, and methods have evolved to simplify this process. New England Biolabs now offers several products that can be used for DNA assembly and cloning. Use this chart to determine which product would work best to assemble your DNA. NEBuilder HiFi Gibson NEB Golden Gate USER® Enzyme DNA Assembly Assembly® Assembly Kit (NEB #M5505) (BsaI-HF®v2, (NEB #E2621) (NEB #E5510) BsmBI-v2) Thermolabile (NEB #E5520) (NEB #E2611) USER II Enzyme (NEB #E2623) (NEB #E1601) (NEB #E1602) (NEB #M5508) PROPERTIES Removes 5´ or 3´ End Mismatches *** * N/A N/A Assembles with High Fidelity at Junctions *** ** *** *** Tolerates Repetitive Sequences at Ends * * *** *** Generates Fully Ligated Product *** *** *** NR Joins dsDNA with Single-stranded Oligo *** ** NR NR Assembles with High Efficiency with Low Amounts of DNA *** ** ** ** Accommodates Flexible Overlap Lengths *** *** * ** APPLICATIONS Simple Cloning (1-2 Fragments) *** *** *** *** 4-6 Fragment Assembly (one pot) *** *** *** *** 7-11 Fragment Assembly (one pot) *** ** *** *** 12-50+ Fragment Assembly (one pot)(1) * * *** NR Template Construction for In vitro Transcription *** *** *** *** Synthetic Whole Genome Assembly *** * * * Multiple Site-directed Mutagenesis *** ** ** ** Library Generation *** *** *** ** KEY Metabolic Pathway Engineering Optimal, recommended product for *** ** *** *** *** selected application TALENs ** ** *** ** ** Works well for selected application Short Hairpin RNA Cloning (shRNA) Will perform selected application, *** ** * * * but is not recommended gRNA Library Generation *** ** * * (1) Please visit neb.com/GoldenGate for Large Fragment (> 10 kb) Assembly *** *** *** ** more information Small Fragment (< 100 bp) Assembly N/A Not applicable to this application *** * *** *** NR Not recommended Use in Successive Rounds of Restriction Enzyme Assembly *** * NR * Enzymes for Innovation Enzymes for Innovation (EFI) is a unique program initiated by NEB to provide enzymes with interesting activities and unique properties to the scientific community, in hopes of enabling the discovery of new and innovative applications. Learn more at www.neb.com/enzymesforinnovation 2 1 0 01 SYNTHETIC BIOLOGY 0 1 NEBuilder® HiFi DNA Assembly NEBuilder HiFi DNA Assembly enables virtually error-free joining of DNA fragments, RECOMMENDED PRODUCTS even those with 5´- and 3´-end mismatches. Available with and without competent E. coli, this flexible kit enables simple and fast seamless cloning utilizing a proprietary NEBuilder HiFi DNA Assembly Cloning Kit high-fidelity polymerase. Make NEBuilder HiFi your first choice for DNA assembly (NEB #E5520) and cloning. NEBuilder HiFi DNA Assembly Master Mix (NEB #E2621) Overview of the NEBuilder HiFi DNA Assembly cloning method NEBuilder HiFi DNA Assembly Bundle for Large Fragments DNA Preparation (NEB #E2623) From: C • Simple and fast seamless cloning in as little as 15 minutes • PCR B Linear A • Restriction enzyme vector + • Use one system for both "standard-size" cloning and larger digestion DNA inserts with 15-30 bp • Synthetic DNA overlapping ends (PCR-amplied) gene assembly products (up to 11 fragments and 22 kb) (e.g., gBlocks) • Single-stranded oligo • DNA can be used immediately for transformation or as template for PCR or RCA NEBuilder HiFi DNA B • Adapts easily for multiple DNA manipulations, Assembly Master Mix A C including site-directed mutagenesis Single-tube reaction • Exonuclease chews Assembled • Enjoy less screening/re-sequencing of constructs, back 5´ ends to create DNA single-stranded 3´ overhangs with virtually error-free, high-fidelity assembly • DNA polymerase lls in gaps within Incubate at 50°C each annealed fragment for 15-60 minutes • Use NEBuilder HiFi in successive rounds of assembly, • DNA ligase seals nicks as it removes 5´- and 3´-end mismatches in the assembled DNA • Bridge two ds-fragments with a synthetic ssDNA oligo for simple and fast construction (e.g., linker insertion Transformation or gRNA library) • No licensing fee requirements from NEB for NEBuilder products DNA Analysis • NEBuilder HiFi DNA Assembly Cloning Kit includes OR OR the NEBuilder HiFi DNA Assembly Master Mix and NEB 5-alpha Competent E. coli RE Digest Colony PCR Sequencing • NEBuilder HiFi DNA Assembly Bundle for Large Fragments includes the NEBuilder HiFi DNA Assembly Master Mix and NEB 10-beta Competent E. coli for assemblies larger NEBuilder HiFi DNA Assembly than 15 kb. can be used for a variety of DNA assembly methods. TOOLS & RESOURCES 2-fragment assembly ssOligo & dsDNA assembly Visit NEBuilderHiFi.com to find: • Online tutorials to help with assembly and primer design • Application notes utilizing NEBuilder HiFi 4-fragment assembly Annealed-oligo assembly 15-bp overlap 25-bp overlap • Access to NEBuilder Assembly Tool, our online Sticky end Blunt end primer design tool High efficiency DOWNLOAD THE NEB AR APP* 3´- and 5´-end mismatch assembly Site-directed mutagenesis Multiple sites How does NEBuilder HiFi DNA Assembly work? NEBuilder HiFi DNA Assembly can be used for a variety of DNA assembly methods. *see back cover for details 3 1 0 01 0 1 SYNTHETIC BIOLOGY Gibson Assembly Gibson Assembly enables multiple, overlapping DNA fragments to be joined in a single- RECOMMENDED PRODUCTS tube isothermal reaction, with no additional sequence added (scar-less). The Gibson Assembly Master Mix includes three different enzymatic activities that perform in a Gibson Assembly Cloning Kit (NEB #E5510) single buffer. The assembled, fully-sealed construct is then transformed into NEB 5-alpha competent E. coli. The entire protocol, from assembly to transformation, takes just under Gibson Assembly Master Mix (NEB #E2611) two hours. • Visit NEBGibson.com to learn more Cell-free Expression ® NEBExpress Cell-free E. coli Protein Synthesis System RECOMMENDED PRODUCTS The NEBExpress Cell-free E. coli Protein Synthesis System is a coupled transcription/ translation system designed to synthesize proteins encoded by a DNA or mRNA NEBExpress Cell-free E. coli Protein template under the control of a T7 RNA Polymerase promoter. The system offers high Synthesis System expression levels, the ability to produce high molecular weight proteins, scalability, and (NEB #E5360) is cost-effective for high throughput expression applications. The speed and robustness • Synthesize high yields of protein (typically 0.5 mg/ml) of the system facilitates protein synthesis in applications such as protein engineering, • Protein can be synthesized and visualized in approximately mutagenesis studies and enzyme screening. 2–4 hours The NEBExpress Cell-free E. coli Protein Synthesis System contains all the components • Synthesize target proteins ranging from 17 to 230 kDa required for protein synthesis, except for the target template DNA. It is a combination of a highly active cell extract from a genetically engineered strain, a reaction buffer, and • Templates can be plasmid DNA, linear DNA, or mRNA an optimized T7 RNA Polymerase, which together yield robust expression of a wide • RNase contamination can be inhibited by the supplied variety of protein targets ranging from 17 to 230 kDa. RNase inhibitor, eliminating clean-up steps The NEBExpress Cell-free E. coli Protein Synthesis System can be used to express a • Flexible reaction conditions achieve maximum yield; protein wide range of proteins synthesis can be sustained for 10 hours at 37°C or up to 24 hours at lower temperatures M neg bGalS bGal SP6 FLuc BglA CitS vGFP GMK DHFR CALM 200 • Reactions can be miniaturized or scaled up to yield milligram quantities of protein 100 PURExpress In Vitro Protein Synthesis Kit (NEB #E6800) 60 • Suitable for circular or linear DNA template • Visualize synthesized protein directly on a Coomassie stained gel 25 50 µl reactions containing 250 ng template • Protein expression in approximately 2 hours DNA were incubated at 37°C for 3 hours. The red dot indicates the protein of interest. • Templates can be plasmid DNA, linear DNA or mRNA 15 M = Unstained Protein Standard, Broad Range (NEB #P7717), “neg” = negative • Transcription/translation components can be removed by control, no DNA affinity chromatography PURExpress® In Vitro Protein Synthesis Kit A rapid method for gene expression analysis, PURExpress is a novel cell-free transcription/translation system reconstituted from purified components necessary for E. coli translation. Synthesize a wide range of proteins free of modification or degradation by simply mixing two tubes followed by the addition of template DNA. With results available in only a few hours, PURExpress saves valuable laboratory time and is ideal for high throughput technologies. Product selection includes the original kit, with all components in two tubes, as well as options for protein translation experiments, protein synthesis/ribosomal display experiments and synthesis with modified amino acids. 4 1 0 01 SYNTHETIC BIOLOGY 0 1 Golden Gate Assembly The efficient and seamless assembly of DNA fragments, commonly referred to as Golden RECOMMENDED
Recommended publications
  • Extensive Experience. Superior Quality

    Extensive Experience. Superior Quality

    EXTENSIVE EXPERIENCE. SUPERIOR QUALITY. INNOVATIVE SOLUTIONS. R&D AND MANUFACTURING SUPPORT FOR THE BIOTECHNOLOGY AND BIOPHARMA INDUSTRY LET NEB’S SCIENTIFIC EXPERTISE HELP DRIVE YOUR INNOVATIONS FORWARD In recent years, there has been a dramatic rise in the number of biologics and companion diagnostics developed and commercialized, and these important areas of biotechnology are more reliant than ever on cutting edge molecular biology tools and techniques. For instance, companion diagnostics, based on DNA amplification, can foster a better match of effective therapies with patients; personalized medicines, utilizing next-generation sequencing, can also help tailor treatments for specific patients; and a wide range of biologics is now being developed as a result of advancements in recombinant technologies. 2 COLLABORATION We’re here to champion your efforts. We have extensive scientific expertise and can devote the necessary attention to developing solutions for your specific needs – along with the manufacturing capacity to scale up quickly. Whether you’re looking for a custom version of an existing product, to find a new way around a development roadblock, or to license one of our technologies, our team is ready to work with you. PRODUCT PORTFOLIO We can provide an entire suite of enzymes THE NEB DIFFERENCE that have the potential to accelerate your discovery efforts. Our expertise in At NEB, we have decades of experience enzymology has enabled us to develop unique enzymes that enable faster, more robust in practicing molecular biology, which has workflows. Further, enzymes can be provided both in small aliquots and in bulk, in different led to the introduction of a broad product formats (liquid, lyophilized and glycerol-free), portfolio that has the potential to touch as well as packaged into complete kits.
  • “ ” Enabling Real-Time Business Growth with SAP S/4HANA® In

    “ ” Enabling Real-Time Business Growth with SAP S/4HANA® In

    Enabling real-time business growth with SAP S/4HANA® in the cloud Case Study: New England Biolabs An SAP HANA® and S/4 Migration Case Study Scientists today are constantly under pressure to quickly already difficult task, consistent, double-digit growth was understand the genetic makeup of new bacteria strains, rapidly powering the business forward, but exposed gaps in help diagnose new diseases and create life-saving the IT infrastructure. treatments for use worldwide. Their implementation of the SAP ECC 6.0 platform was As a global leader in the discovery, development and lacking key functionality in the areas of production planning, commercialization of recombinant and native enzymes for eProcurement and product costing. The need for a stable, genomic research, New England Biolabs (NEB) is an and more importantly scalable platform to support the innovator of technologies from basic molecular biology rapidly evolving business became critical. As NEB began to through to sample preparation for next-generation evaluate their options, they were faced with the realities of sequencing and high throughput genomics for the life having a small IT team who didn’t have the necessary SAP sciences industry. Headquartered in the US with seven technical experience to implement a “cloud first” strategy global subsidiaries, they are at the forefront of medical and and support a large scale ERP effort. technological developments. The Competitive Edge Assessing the Current Landscape NEB began the process of looking for the right provider to A key offering of New England Biolabs business is the augment their team and initiatives. “We put out a bid to NEBnow Freezer Program, which consists of teams working see which hosting provider best aligned with our needs, and closely with institutions to customize inventory best suited Symmetry’s full suite of services stood out above the rest,” to research programs.
  • Methylase-Assisted Subcloning for High Throughput Biobrick Assembly

    Methylase-Assisted Subcloning for High Throughput Biobrick Assembly

    Methylase-assisted subcloning for high throughput BioBrick assembly Ichiro Matsumura Emory University School of Medicine, Department of Biochemistry, Atlanta, GA, United States of America ABSTRACT The BioBrick standard makes possible iterated pairwise assembly of cloned parts with- out any depletion of unique restriction sites. Every part that conforms to the standard is compatible with every other part, thereby fostering a worldwide user community. The assembly methods, however, are labor intensive or inefficient compared to some newer ones so the standard may be falling out of favor. An easier way to assemble BioBricks is described herein. Plasmids encoding BioBrick parts are purified from Escherichia coli cells that express a foreign site-specific DNA methyltransferase, so that each is subsequently protected in vitro from the activity of a particular restriction endonuclease. Each plasmid is double-digested and all resulting restriction fragments are ligated together without gel purification. The ligation products are subsequently double-digested with another pair of restriction endonucleases so only the desired insert-recipient vector construct retains the capacity to transform E. coli. This 4R/2M BioBrick assembly protocol is more efficient and accurate than established workflows including 3A assembly. It is also much easier than gel purification to miniaturize, automate and perform more assembly reactions in parallel. As such, it should streamline DNA assembly for the existing community of BioBrick users, and possibly encourage others to join. Subjects Bioengineering, Molecular Biology, Synthetic Biology Keywords BioBrick assembly, Methylase-assisted cloning, Synthetic biology, Laboratory automation, DNA methyltransferase Submitted 27 April 2020 Accepted 10 August 2020 Published 11 September 2020 INTRODUCTION Corresponding author A bottleneck in many synthetic biology projects is the physical linkage of cloned synthetic Ichiro Matsumura, [email protected] genes (``parts'') to each other to form longer functional assemblies (``devices'').
  • A New Biobrick Assembly Strategy Designed for Facile Protein Engineering

    A New Biobrick Assembly Strategy Designed for Facile Protein Engineering

    A New Biobrick Assembly Strategy Designed for Facile Protein Engineering Ira E. Phillips∗ and Pamela A. Silver∗ April 18, 2006 Abstract The existing biobrick assembly technique[1] provides a straightforward way to combine standardized biological components, termed biobricks. This system, however, is limited in that each protein-encoding biobrick must contain a complete translated region. Signal sequences or other pro- tein domains often convey a specific function to the protein to which they are attached; hence, each domain should be considered an independent biological part. With the current assembly technique, assembling such parts is not possible. This paper presents a revised assembly strategy that is compatible with the current biobrick definition and permits the construction of fusion proteins. Introduction The standard biobrick assembly technique was created in an attempt to simplify the construction of long concatemeric pieces of DNA often used in synthetic biology [1]. Previously existing techniques were limiting in that one often needed to design a unique cloning strategy for each desired construct. Moreover, the intermediates in the cloning of one construct would be of little value in creating other constructs. As a solution to these problems, T. Knight developed a novel cloning strategy that permits standardization of biological parts or biobricks [1]. Each biobrick can be placed in front of or behind another biobrick using a standard protocol that is independent of the content of the parts involved. (To insert a biobrick in front of another, simply digest the upstream biobrick with EcoRI and SpeI. Cut out this insert and ligate into a vector containing the second part cut with EcoRI and XbaI.
  • Curriculum Vitae SIR RICHARD JOHN ROBERTS ADDRESS PERSONAL

    Curriculum Vitae SIR RICHARD JOHN ROBERTS ADDRESS PERSONAL

    Curriculum Vitae SIR RICHARD JOHN ROBERTS ADDRESS New England Biolabs 240 County Road, Ipswich, MA 02138 USA Email: [email protected] Telephone: (978) 380-7405 / Fax: (978) 380-7406 PERSONAL Born on September 6, 1943, Derby, England EDUCATION 1962-1965 University of Sheffield, Sheffield, England B.Sc. in Chemistry 1966-1968 University of Sheffield, Sheffield, England Ph.D. in Organic Chemistry POSITIONS 2005- Chief Scientific Officer, New England Biolabs 1992-2005 Research Director, New England Biolabs 1986-92 Assistant Director for Research, Cold Spring Harbor Laboratory 1972-86 Senior Staff Investigator, Cold Spring Harbor Laboratory 1971-1972 Research Associate in Biochemistry, Harvard University 1969-1970 Research Fellow, Harvard University OUTSIDE ACTIVITIES 1974-1992 Consultant and Chairman of Scientific Advisory Board New England Biolabs 1977-1985 Scientific Advisory Board, Genex Corp. 1977-1987 Editorial Board: Nucleic Acids Research 1979-1984 Editorial Board: Journal of Biological Chemistry 1982-1989 Member: National Advisory Committee of GENBANK 1984-1986 Member: National Advisory Committee of BIONET 1985-1988 Panel member: NIH Study Section in Biochemistry. 1985-2002 Editorial Board: Bioinformatics (formerly CABIOS) 1987-1990 Chairman: National Advisory Committee of BIONET 1987-2009 Senior Executive Editor: Nucleic Acids Research 1990-1992 Panel member: NCI Cancer Centers Support Grant Review Committee 1993-1995 Panel member: NLM Study Section/Comp. Biol. 1994-2000 Scientific Advisory Board, Molecular Tool 1994- Patron of the Oxford International Biomedical Center 1996-1998 Visiting Professor, University of Bath, UK. 1996-2000 Chairman, NCI Board of Scientific Counselors 1996-1999 Scientific Advisory Board, Oxford Molecular Group 1997-2001 Editorial Board: Current Opinion Chem. Biol.
  • A Biobrick Compatible Strategy for Genetic Modification of Plants Boyle Et Al

    A Biobrick Compatible Strategy for Genetic Modification of Plants Boyle Et Al

    A BioBrick compatible strategy for genetic modification of plants Boyle et al. Boyle et al. Journal of Biological Engineering 2012, 6:8 http://www.jbioleng.org/content/6/1/8 Boyle et al. Journal of Biological Engineering 2012, 6:8 http://www.jbioleng.org/content/6/1/8 METHODOLOGY Open Access A BioBrick compatible strategy for genetic modification of plants Patrick M Boyle1†, Devin R Burrill1†, Mara C Inniss1†, Christina M Agapakis1,7†, Aaron Deardon2, Jonathan G DeWerd2, Michael A Gedeon2, Jacqueline Y Quinn2, Morgan L Paull2, Anugraha M Raman2, Mark R Theilmann2, Lu Wang2, Julia C Winn2, Oliver Medvedik3, Kurt Schellenberg4, Karmella A Haynes1,8, Alain Viel3, Tamara J Brenner3, George M Church5,6, Jagesh V Shah1* and Pamela A Silver1,5* Abstract Background: Plant biotechnology can be leveraged to produce food, fuel, medicine, and materials. Standardized methods advocated by the synthetic biology community can accelerate the plant design cycle, ultimately making plant engineering more widely accessible to bioengineers who can contribute diverse creative input to the design process. Results: This paper presents work done largely by undergraduate students participating in the 2010 International Genetically Engineered Machines (iGEM) competition. Described here is a framework for engineering the model plant Arabidopsis thaliana with standardized, BioBrick compatible vectors and parts available through the Registry of Standard Biological Parts (www.partsregistry.org). This system was used to engineer a proof-of-concept plant that exogenously expresses the taste-inverting protein miraculin. Conclusions: Our work is intended to encourage future iGEM teams and other synthetic biologists to use plants as a genetic chassis.
  • Before Peer Production: Infrastructure Gaps and the Architecture of Openness in Synthetic Biology

    Before Peer Production: Infrastructure Gaps and the Architecture of Openness in Synthetic Biology

    BEFORE PEER PRODUCTION: INFRASTRUCTURE GAPS AND THE ARCHITECTURE OF OPENNESS IN SYNTHETIC BIOLOGY David Singh Grewal* In memoriam Mark Fischer (1950 – 2015)µ * Professor of Law, Yale Law School, and Director, BioBricks Foundation. The views expressed here are my own, and do not reflect the views of any of the organizations or entities with which I am or have been affiliated. Among those to whom I owe thanks, I am especially grateful to Drew Endy, President of the BioBricks Foundation (BBF) who worked to educate me about synthetic biology, and later invited me to join the board of directors of the BBF, and to the late Mark Fischer, who was the lead drafter (along with Drew Endy, Lee Crews, and myself) of the BioBrick™ Public Agreement, and to whose memory this Article is dedicated. I am also grateful to other past and present directors and staff of the BBF, including Richard Johnson, Linda Kahl, Tom Knight, Thane Krier, Nathalie Kuldell, Holly Million, Jack Newman, Randy Rettberg, and Pamela Silver. I have benefitted from conversations about synthetic biology and open source theory with a number of other scientists, including Rob Carlson, George Church, Jason Kelly, Manu Prakash, Zach Serber, Reshma Shetty, Christina Smolke, Ron Weiss and with a number of lawyers, scholars, and open source advocates including Yochai Benkler, James Boyle, Daniela Cammack, Paul Cammack, Paul Goldstein, Hank Greely, Janet Hope, Margot Kaminski, Mark Lemley, Stephen Maurer, Eben Moglen, Lisa Ouellette, Jedediah Purdy, Arti Rai, Pamela Samuelson, Jason Schultz, and Andrew Torrance, and especially Talli Somekh, who first introduced me to synthetic biology and noted the connections between my work in network theory and new developments in biotechnology.
  • Jessica Brown, New England Biolabs Foundation, and IUCN-WCPA Protected Landscapes Task Force - with Contributions from Grazia Borrini- Feyerabend and Ashish Kothari

    Jessica Brown, New England Biolabs Foundation, and IUCN-WCPA Protected Landscapes Task Force - with Contributions from Grazia Borrini- Feyerabend and Ashish Kothari

    Jessica Brown, New England Biolabs Foundation, and IUCN-WCPA Protected Landscapes Task Force - with contributions from Grazia Borrini- Feyerabend and Ashish Kothari Rice Terraces of the Philippines Cordilleras Why stewardship? • Worldwide, conservation strategies are becoming increasingly bio-regional. • New approaches to protected areas—based on inclusive approaches, partnerships, and linkages. • Growing understanding of the link between nature and culture—landscapes shaped by human culture as well as the forces of nature. Protected Area An area of land and/or sea especially dedicated to the protection and maintenance of biological diversity, and of natural and associated cultural resources, and managed through legal or other effective means. Indigenous Peoples’ and Community Conserved Areas and Territories -- ICCAs “…natural and modified ecosystems including significant biodiversity values, ecological services and cultural values voluntarily conserved by indigenous peoples & local communities through customary laws or other effective means…” • Specific indigenous three defining peoples or local communities characteristics of ICCAs (sedentary or mobile) are closely “concerned” about an area (related to it culturally and/or because of livelihoods) • Such communities hold power de facto -- if not also de jure -- in deciding, implementing & enforcing management decisions The voluntary management decisions and efforts of such communities achieve conservation results— although their main intention may not be necessarily related to conservation.
  • Synthetic Biology for Biotechnology- Regulatory Decision Makers from the Americas Th Th (San Jose, 16 and 17 March 2016)

    Synthetic Biology for Biotechnology- Regulatory Decision Makers from the Americas Th Th (San Jose, 16 and 17 March 2016)

    15/03/2016 Proceedings of the First Seminar on Synthetic Biology for Biotechnology- Regulatory Decision Makers from the Americas th th (San Jose, 16 and 17 March 2016) Inter-American Institute for Cooperation on Agriculture (IICA) Technical Editor: Pedro J. Rocha Salavarrieta Organized por: IICA and U.S. Department of Agriculture (USDA) Financed by: USDA & IICA Inter-American Institute for Cooperation on Agriculture (IICA), 2017 Proceedings of the First Seminar on Synthetic Biology for Biotechnology-Regulatory Decision Makers from the Americas by IICA is published under license from Creative Commons Attribution-ShareAlike 3.0 IGO (CC-BY-SA 3.0 IGO) (http://creativecommons.org/licenses/by-sa/3.0/igo/) Based on a work at www.iica.int IICA encourages fair use of this document. Proper citation is requested. Inter-American Institute for Cooperation on Agriculture (IICA, CR), 2017. Proceedings of the First Seminar on Synthetic Biology for Biotechnology-Regulatory Decision Makers from the Americas (San Jose, 16th and 17th March 2016). Technical Editor: P. J. Rocha. San José, CR, IICA. Disclaimer: The content of this publication is responsibility of its authors and does not reflect IICA´s official position. This publication is also available in electronic (PDF) format from Institute’s Web site: http://www.iica.int. Editorial coordination: Pedro J. Rocha Mechanical editing: Pedro J. Rocha Text translation: IICA Layout: Pedro J. Rocha Cover design: Pedro J. Rocha Proceedings of the First Seminar on Synthetic Biology for Biotechnology-Regulatory Decision Makers from the Americas (2016: San Jose, Costa Rica) / Inter-American Institute for Cooperation on Agriculture, United States Department of Agriculture.
  • Synthetic Biology: Scope, Applications and Implications

    Synthetic Biology: Scope, Applications and Implications

    Cover and back spread:Cover and back spread 29/4/09 14:42 Page 2 Synthetic Biology: scope, applications and implications Synthetic biology josi q7v2:Synthetic biology 29/4/09 14:41 Page 1 Synthetic Biology: scope, applications and implications © The Royal Academy of Engineering ISBN: 1-903496-44-6 May 2009 Published by The Royal Academy of Engineering 3 Carlton House Terrace London SW1Y 5DG Copies of this report are available online at www.raeng.org.uk/synbio Tel: 020 7766 0600 Fax: 020 7930 1549 www.raeng.org.uk Registered Charity Number: 293074 Synthetic biology josi q7v2:Synthetic biology 29/4/09 14:41 Page 2 Contents Executive summary Recommendation 1 Recommendation 2 Recommendation 3 Chapter 1– An Introduction 1.1: What is synthetic biology? 1.1.1: Biological systems 1.1.2: Systems approach 1.2: Relevant aspects of biological systems 1.2.1: Living systems 1.2.2: Self-organisation 1.2.3: Noise 1.2.4: Feedback and cell signalling 1.2.5: Biological complexity 1.3: The emergence of synthetic biology 1.3.1: Why now? 1.3.2: Developments in ICT 1.3.3: Developments in biology 1.3.4: The relationship between systems biology and synthetic biology 1.3.5: The Engineering design cycle and rational design in synthetic biology 1.3.6: Bioparts 1.3.7: Potential areas of application 1.3.8: Parallels in synthetic chemistry 1.3.9 ‘Bottom-up’ approaches in synthetic biology Chapter 2 – Fundamental 2.1: Technological enablers techniques in synthetic biology 2.1.1: Computational modelling 2.1.2: DNA sequencing 2.1.3: DNA synthesis 2.1.4: Yields 2.1.5: Future trends in modern synthesis 2.1.6: Large scale DNA oligonucleotide synthesis 2.1.7: Potential for innovation and microfluidics 2.1.
  • Bionano Genomics Launches Enhanced Genome Mapping Coverage Features with New Software Tools

    Bionano Genomics Launches Enhanced Genome Mapping Coverage Features with New Software Tools

    BioNano Genomics Launches Enhanced Genome Mapping Coverage Features with New Software Tools Availability of a new enzyme from New England BioLabs Inc. further expands BioNano genome mapping capabilities SAN DIEGO, CA – May 4, 2016 – BioNano Genomics, the leader in physical genome mapping, today announced updates regarding expansions of its product offerings and capabilities. Launching Enhanced Mapping Capability BioNano announced the launch of a new version of its IrysView® next-generation mapping (NGM) software (Version 2.4) which further improves the contiguity of genome assemblies of physical genome maps. This feature allows researchers to stitch together two physical genomic maps to cover a more complete area of the genome allowing for an even broader discovery of Structural Variations. Mark Borodkin, Vice President of Systems Development at BioNano Genomics, remarked, “In a recent article published by bioRxiv, titled ‘Third-generation sequencing and the future of genomics,’ the authors acknowledge the important role that NGM plays in genomic analysis and name BioNano’s Irys System ‘one of the most successful third-generation mapping systems available.’ With this software update, we are further advancing our NGM capabilities to produce the longest genome information available in the industry. This higher level of contiguity improves completeness, correctness, orientation and resolution of the genome as well as increases the specificity and sensitivity of structural variation identification.” Introducing a New Enzyme To exploit this new Irysview® mapping software feature, researchers need to select different enzymes to barcode, or tag, the genome at specific locations. The availability of the new enzyme Nb.BssSI by New England Biolabs, Inc. (NEB®), expands the number of genomes that can be integrated by NGM and complements the existing portfolio of enzymes, thereby providing an additional, independent means to optimize the mapping and analysis of genomes.
  • SELVARAJAH-DOCUMENT-2019.Pdf (1.994Mb)

    SELVARAJAH-DOCUMENT-2019.Pdf (1.994Mb)

    Development of a Set of Standardized Toehold Switch Riboregulators and Fluorescent Reporter Proteins for Genetic Circuit Prototyping. The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Selvarajah, Vinoo. 2019. Development of a Set of Standardized Toehold Switch Riboregulators and Fluorescent Reporter Proteins for Genetic Circuit Prototyping.. Master's thesis, Harvard Extension School. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37365394 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Development of a Set of Standardized Toehold Switch Riboregulators and Fluorescent Reporter Proteins for Genetic Circuit Prototyping. Vinoo Selvarajah A Thesis in the Field of Biology for the Degree of Master of Liberal Arts in Extension Studies Harvard University November 2019 Copyright 2019 Vinoo Selvarajah Abstract The goal of this research was the creation and characterization of a new library of Type IIS standardized biological parts that can be used to construct expression devices for reporter proteins with precise and reliable control. Toehold switches are one such element of control. As de-novo designed translational riboregulators, they can regulate ribosomal activity on an mRNA, thereby affecting post-transcriptional gene expression. Toehold switches act as a cognate pair of RNAs: the switch RNA interferes with ribosomal activity until a target RNA complementarily binds to the switch to allow for ribosomal binding and gene expression.